Viewing Study NCT06304194



Ignite Creation Date: 2024-05-06 @ 8:14 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06304194
Status: RECRUITING
Last Update Posted: 2024-03-12
First Post: 2024-02-23

Brief Title: Molecular Characterizazion and Biological Samples Centralisation of Patients Affected by Oncoematolofic Pathology
Sponsor: Meyer Childrens Hospital IRCCS
Organization: Meyer Childrens Hospital IRCCS

Study Overview

Official Title: Pilot Study to Assess the Feasibility of Centralizing Biological Samples at Onset and Relapse of Patients Referred to CROP Centers for Molecular Characterization of Oncohematologic Pathology
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Currently the molecular characterization of onco-hematological onco-immunological and hematological diseases at onset or in relapse of patients with suspected diagnosis afferent to the CROP centers is done through centralization of biological samples at reference laboratories outside the Tuscany Region

In order to preserve the wealth of clinical and biological data and use it for the benefit of present and future patients treated at the CROP centers it is useful to evaluate the feasibility of centralization and molecular typing of mutations present in tumor tissue at the IRCCS AOU Meyer Oncohematology Laboratories and subsequently the analysis of clinical data from patients with diseases not under study to lay the foundations of a translational database that can then be associated with a biobank in the future

This will enable a targeted contribution to pediatric oncohematology research investing in possible targeted therapies with those patient subgroups that benefit from personalized disease assessment in mind The goal of the project is to improve the regional infrastructure dedicated to organized data collection and management of biological samples in adequate time resulting in better and more comprehensive data collection
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None